CytoDyn (CYDY) Stock Chart & Stock Price History $0.31 -0.01 (-3.01%) As of 07/15/2025 03:58 PM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock CytoDyn Stock Price Performance The CytoDyn (CYDY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 115.39%, with a year-to-date return of 181.95%. In the past month, the stock has decreased 11.63%, reflecting recent market activity. As of the latest close, CytoDyn traded at $0.31 with a market cap of $387.10 million and volume of 747,000 shares. Five years ago, the stock traded at $5.49, representing a 94.37% decrease over that period. At the time, it had a market cap of $2.80 billion and a volume of 7.08 million shares. Receive CYDY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.81%1 Month Performance-11.63%3 Month Performance+53.88%Year-To-Date Performance+181.95%1 Year Performance+115.39%5 Year Performance-94.37% CYDY Stock Chart for Wednesday, July, 16, 2025 CYDY Chart by TradingView CytoDyn Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$0.32$0.31-2.98%$0.33$0.30747,000 shs$387.10 million07/14/2025$0.32$0.32+1.21%$0.33$0.301.06 million shs$398.99 million07/11/2025$0.32$0.32-1.01%$0.32$0.29972,342 shs$394.23 million07/10/2025$0.31$0.32+1.79%$0.35$0.31963,063 shs$398.24 million07/09/2025$0.31$0.31+1.63%$0.33$0.301.43 million shs$391.23 million07/08/2025$0.32$0.31-3.42%$0.35$0.302.58 million shs$384.97 million07/07/2025$0.29$0.32+11.75%$0.34$0.291.84 million shs$398.61 million07/04/2025$0.29$0.29$0.29$0.28413,710 shs$356.69 million07/03/2025$0.27$0.29+5.56%$0.29$0.28413,710 shs$356.69 million07/02/2025$0.28$0.27-2.21%$0.29$0.261.50 million shs$337.91 million Get the Latest News and Ratings for CYDY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$0.27$0.28+1.32%$0.32$0.274.55 million shs$345.55 million06/30/2025$0.26$0.27+5.83%$0.28$0.261.12 million shs$341.04 million06/27/2025$0.30$0.26-14.17%$0.31$0.252.83 million shs$321.66 million06/26/2025$0.31$0.30-2.06%$0.32$0.291.70 million shs$374.75 million06/25/2025$0.32$0.31-5.46%$0.34$0.302.14 million shs$382.62 million06/24/2025$0.31$0.32+4.38%$0.34$0.31885,010 shs$404.73 million06/23/2025$0.31$0.31+0.13%$0.33$0.301.28 million shs$387.69 million06/20/2025$0.32$0.31-1.59%$0.32$0.301.16 million shs$387.19 million06/19/2025$0.32$0.32$0.35$0.312.78 million shs$393.43 million06/18/2025$0.34$0.32-7.52%$0.35$0.312.78 million shs$393.43 million06/17/2025$0.35$0.34-2.69%$0.36$0.331.13 million shs$425.40 million06/16/2025$0.35$0.35-0.96%$0.36$0.33851,721 shs$437.14 million Related Companies EVO Stock Chart VERA Stock Chart ETNB Stock Chart JANX Stock Chart BHVN Stock Chart ANIP Stock Chart EVTCY Stock Chart EWTX Stock Chart TVTX Stock Chart MESO Stock Chart Receive CYDY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:CYDY) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytoDyn Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytoDyn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYDY Stock Alerts